Head-To-Head Review: Edwards Lifesciences (NYSE:EW) vs. Safe Pro Group Inc. Common Stock (NASDAQ:SPAI)

Safe Pro Group Inc. Common Stock (NASDAQ:SPAI) and Edwards Lifesciences (NYSE:EW) are both business services companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, earnings, institutional ownership, valuation, risk, analyst recommendations and dividends.

Insider & Institutional Ownership

79.5% of Edwards Lifesciences shares are owned by institutional investors. 1.3% of Edwards Lifesciences shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Valuation & Earnings

This table compares Safe Pro Group Inc. Common Stock and Edwards Lifesciences”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Safe Pro Group Inc. Common Stock	$1.56 million	23.39	N/A	N/A	N/A
Edwards Lifesciences	$5.44 billion	7.66	$4.17 billion	$6.97	10.17

Edwards Lifesciences has higher revenue and earnings than Safe Pro Group Inc. Common Stock.

Profitability

This table compares Safe Pro Group Inc. Common Stock and Edwards Lifesciences’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Safe Pro Group Inc. Common Stock	N/A	N/A	N/A
Edwards Lifesciences	72.93%	19.40%	14.37%

Analyst Ratings

This is a summary of current recommendations and price targets for Safe Pro Group Inc. Common Stock and Edwards Lifesciences, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Safe Pro Group Inc. Common Stock	0	0	0	0	0.00
Edwards Lifesciences	1	13	11	0	2.40

Edwards Lifesciences has a consensus target price of $79.95, suggesting a potential upside of 12.77%. Given Edwards Lifesciences’ stronger consensus rating and higher probable upside, analysts plainly believe Edwards Lifesciences is more favorable than Safe Pro Group Inc. Common Stock.

Summary

Edwards Lifesciences beats Safe Pro Group Inc. Common Stock on 9 of the 10 factors compared between the two stocks.

About Safe Pro Group Inc. Common Stock

Safe Pro Group, Inc. engages in the provision and acquisition of security and protection products. Its products include Artificial Intelligence (AI) and Machine Learning (ML) software technology and photogrammetry analysis tools, bullet and blast resistant personal protection equipment, and aerial managed services and mission-critical uncrewed solutions. The firm operates through the following segments: Safe-PRO USA, Airborne Response, and Safe Pro AI. The company was founded by Daniyel Erdberg on December 15, 2021 and is headquartered in Aventura, FL.

About Edwards Lifesciences

Edwards Lifesciences Corporation provides products and technologies for structural heart disease and critical care monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL PRECISION and Cardioband names. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; INSPIRIS RESILLA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valves conduit for complex combined procedures; and MITRIS RESILIA valve. In addition, it offers critical care solutions, including hemodynamic monitoring systems to measure a patient’s heart function and fluid status in surgical and intensive care settings under the FloTrac, Acumen IQ sensors, ClearSight, Acumen IQ cuffs, and ForeSight names; HemoSphere, a monitoring platform that displays physiological information; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.